Accordingly, people with type 2 diabetes, cardiovascular disease, heart failure, or chronic kidney disease should be treated appropriately with an SGLT-2 inhibitor or GLP-1RA, even because more adults with type 2 diabetes in the US have suboptimal glycemic control now compared to 10 years ago, associated with a resurgence in vascular diabetic complications [32]
Consuming an excess of B vitamins, vitamin C, and beta carotene may also be responsible
Steroids: Often increase appetite and encourage fat storage
Selenium: biochemical role as a component of glutathione peroxidase
This practice also helps them prevent intolerable side effects, as lower doses tend to have fewer adverse effects
Pratt also said she's concerned that Kennedy's battle with the FDA could inhibit FDA oversight of compounding pharmacies making copycat versions of GLP-1 drugs